Related Experiment Video
Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis e: epidemiology and natural history
1Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
Hepatitis E virus (HEV) causes liver disease with distinct patterns globally. Genotypes 1 and 2 cause acute hepatitis in developing nations, while genotypes 3 and 4 lead to zoonotic infections and chronic disease in developed areas.
Area of Science:
- Hepatology
- Virology
- Epidemiology
Background:
- Hepatitis E is a significant global health concern caused by the Hepatitis E virus (HEV).
- HEV exists in four genotypes (1-4), with distinct transmission routes and clinical outcomes.
- HEV infection presents different epidemiological patterns in developing versus developed regions.
Purpose of the Study:
- To delineate the distinct epidemiological patterns of Hepatitis E infection worldwide.
- To understand the roles of different HEV genotypes in disease transmission and severity.
- To highlight variations in HEV infection outcomes based on geographic location and host factors.
Main Methods:
- Review of global epidemiological data on Hepatitis E virus (HEV) infection.
- Analysis of HEV genotype distribution and associated clinical presentations.
- Comparison of disease patterns in high-endemicity (Asia, Africa) versus low-endemicity (developed) regions.
Main Results:
- High-endemicity areas experience outbreaks of acute hepatitis from genotypes 1 and 2 HEV via fecal-oral waterborne transmission.
- Low-endemicity areas report sporadic, locally-acquired genotype 3 or 4 HEV infections, often zoonotic.
- Chronic HEV infection, leading to liver injury, is documented in immunosuppressed individuals in developed regions.
Conclusions:
- HEV exhibits diverse epidemiological behaviors globally, influenced by viral genotype and socioeconomic factors.
- Understanding these patterns is crucial for targeted prevention and control strategies.
- Further research is needed to elucidate the biological mechanisms behind these differing HEV patterns.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Introduction to Epidemiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Infectious Diseases and Their Occurrence
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

